Abstract: A display device and a method of the manufacturing the display device is provided. The display device includes a substrate, a plurality of island pattern areas, a valley area partitioning the plurality of island pattern areas, a light emitting element emitting light, and a pixel driving part including a first subpixel driving part and a second subpixel driving part and supplying a driving current to the light emitting element. The plurality of island pattern areas include a first island pattern area in which the first subpixel driving part is disposed, and a second island pattern area in which the second subpixel driving part is disposed.

Abstract: The present disclosure provides a sustained formulation for prevention or treatment of autoimmune disease, comprising microparticles comprising naltrexone or pharmaceutically acceptable salts thereof, and biodegradable polymers, and a method using the same. Accordingly, it may be used to prevent or treat autoimmune diseases for a prolonged period of time with a single administration.

Abstract: A lipid nanoparticles manufacturing chip includes a mixer unit for forming a mixed solution by mixing a first raw material containing an active ingredient and a second raw material containing a lipid, a dilution unit that is connected to the mixer unit and dilutes the mixed solution using a diluent solution to make a diluted mixed solution, and a concentration unit connected to the dilution unit and for obtaining a concentrated solution by concentrating lipid nanoparticles (LNP) from the diluted mixed solution.

Abstract: A composition for sustained-release injection comprising deslorelin, can prevent initial over-release by adjusting the release rate of deslorelin at a target site and can exhibit the effect of deslorelin for 1 month or more by being exposed in an amount enough to show the effect of deslorelin. Further, the microparticles can prepare microparticles that have a uniform particle size and are capable of exhibiting the effect of continuously releasing deslorelin for a long time.

Abstract: A microparticle producing system using microfluidics and a controlling method thereof, and specifically, to a microparticle producing system that may stably transport droplets produced using microfluidics without agglomeration or destruction, compared to the conventional art, and a method of controlling the microparticle producing system to transport the droplets more stably in the microparticle producing system. By the microparticle producing system and the controlling method thereof, which are disclosed herein, droplets produced by the microparticle producing system using microfluidics may be stably transported without agglomeration or destruction, resulting in more effective microparticle production.

Abstract: The present disclosure provides a sustained formulation for prevention or treatment of autoimmune disease, comprising microparticles comprising naltrexone or pharmaceutically acceptable salts thereof, and biodegradable polymers, and a method using the same. Accordingly, it may be used to prevent or treat autoimmune diseases for a prolonged period of time with a single administration.

Abstract: A solvent removing apparatus includes a container containing an emulsion comprising a first raw material of a continuous phase and a second raw material of a dispersed phase, an impeller rotating in the container to stir the emulsion, and a foam breaker spaced apart from the impeller on an upper portion of the impeller, positioned below a surface of the emulsion to be submerged in the emulsion when the emulsion is calm, and rotating to reduce foam generated during stirring of the emulsion.

Abstract: The present invention provides microparticles containing leuprolide and a method for producing the same. When the microparticles are administered by injection, they may lower pain due to their small size, control the release rate of leuprolide at a target site, prevent excessive release of leuprolide at an initial stage, enable exposure to a sufficient amount of the drug to exhibit the effect of leuprolide, and exhibit the effect of leuprolide for 1 month or more. The present invention also provides a method for producing microparticles, in which the microparticles have a uniform particle size and a smooth surface and may exhibit the effect of releasing leuprolide sustainably over a long period of time.

Abstract: Disclosed is a cooling system for an electric power system for a vehicle capable of selectively cooling a power component used while the vehicle travels or is charged.

Abstract: A microparticle producing system using microfluidics and a controlling method thereof, and specifically, to a microparticle producing system that may stably transport droplets produced using microfluidics without agglomeration or destruction, compared to the conventional art, and a method of controlling the microparticle producing system to transport the droplets more stably in the microparticle producing system. By the microparticle producing system and the controlling method thereof, which are disclosed herein, droplets produced by the microparticle producing system using microfluidics may be stably transported without agglomeration or destruction, resulting in more effective microparticle production.

Abstract: A panel flattening assembly includes a first fixing assembly and a second fixing assembly respectively disposed at a first corner and a second corner adjacent to the first corner in a first direction on a rear surface of a display panel; a first supporting member disposed between the first fixing assembly and the second fixing assembly and spaced apart from the display panel; a first displacement adjusting member connected to the first fixing assembly and adjusting a distance between the first fixing assembly and a first end of the first supporting member by adjusting a displacement of the first fixing assembly; and a second displacement adjusting member connected to the second fixing assembly and adjusting a distance between the second fixing assembly and a second end of the first supporting member by adjusting a displacement of the second fixing assembly.

Abstract: The disclosure relates to an operating method of controller, and memory system having the same, the method controls a semiconductor memory device including a plurality of memory blocks. The method includes: receiving read data output according to a first read operation performed on a selected memory block; selecting a read voltage set group from a read retry table based on a read error related indicator providing an indication that an error correction failure has occurred; and selecting a read voltage set from the selected read voltage set group based on whether the read error related indicator is greater than or equal to a predetermined reference value. The selected read voltage set has a minimum average distance with respect to a read voltage set used for the first read operation, and has a minimum first read voltage distance with respect to the read voltage set used for the first read operation.

Abstract: A display device comprises a display panel comprising a base part, and a display layer on an upper surface of the base part, a buffer part at an edge of, beneath, and having a side surface that is aligned with a side surface of, the display panel, a lower frame inside the buffer part, in plan view, beneath the display panel, and including a support part for supporting the display panel, and a pad part beneath a lower surface of the base part and electrically connected to the display layer.

Abstract: The present disclosure provides a capacitor module including: a capacitor; a first housing having a hexahedron shape and having an inner space in which the capacitor is disposed, the first housing including a pair of cooling parts recessed inwards from a pair of parallel surfaces among outer side surfaces thereof such that a refrigerant flows, a pair of cooling channels disposed inside opposite side surfaces perpendicular to the surfaces of the pair of cooling parts such that the pair of cooling parts communicate with each other, and a through-hole configured to connect each of the cooling channels to the outside such that the refrigerant is introduced or discharged therethrough; and a cooling plate coupled to the first housing so as to seal the cooling parts.

Abstract: The present disclosure provides a sustained formulation for prevention or treatment of autoimmune disease, comprising microparticles comprising naltrexone or pharmaceutically acceptable salts thereof, and biodegradable polymers, and a method using the same. Accordingly, it may be used to prevent or treat autoimmune diseases for a prolonged period of time with a single administration.

Abstract: The present invention relates to extended release microparticles comprising a drug, and a preparation method therefor, and when the extended release microparticles comprising a drug are administered in order to replace conventional drugs that should be administered daily or monthly, the drug administration effect can be continuously maintained for one week to three months. In addition, the drug administration effect is maintained for a long time and, simultaneously, microparticles are prepared so as to have the average diameter of a fixed micro-size, and thus an effective drug concentration can be constantly maintained by controlling the release of the drug from the microparticles, and a foreign body sensation and pain can be reduced during drug administration since microparticles having a uniform size are included during application as an injectable drug.

Abstract: The present disclosure relates to a sustained-release injectable composition comprising finasteride, and when the composition is injected as an injection formulation, it is possible to maintain a constant blood concentration for a long time without initial over-release in terms of the degree of release of finasteride, and when the composition is administrated by subcutaneous injection, it is possible to maintain the effect of treating hair loss and benign prostatic hyperplasia continuously for 1 to 3 months.

Abstract: The present disclosure provides sustained-release microparticles comprising a biodegradable polymer and a drug, wherein the biodegradable polymer and the drug are uniformly distributed throughout the particles, and the microparticles do not show an initial excessive release of the drug, and are composed of uniform-sized particles having a particle size distribution width of 35 microns or less analyzed by a particle size analyzer and a specific surface area of the microparticles of 0.75×10?1 to 2.0×10?1 m2/g, thereby exhibiting a sustained release pattern of the drug. The injection composition comprising the drug contained in such microparticles can control the release of the drug for a selected period during injection administration to release an effective drug concentration constantly, and when formulated as an injection product, can reduce foreign body sensation and pain to the subject to enable an injection formulation with high compliance to be provided.

Abstract: The present disclosure relates to a cooking appliance disposed above a household appliance to simultaneously perform a hood function and an oven function. The cooking appliance includes a housing, a base plate configured to be coupled to the housing, a cooking chamber disposed inside the housing, a door coupled to the housing to open and close the cooking chamber, and a deflector spaced apart from a lower end of the door and coupled to a front edge of the base plate to cover the lower end of the door from hot air generated and transferred from a household appliance installed below the base plate.

Abstract: The present invention pertains to a cosmetic composition, quasi-drug composition and pharmaceutical composition containing graphene quantum dots as an active ingredient, and provides a composition that prevents skin aging by providing a skin regenerating, anti-wrinkle, moisturizing or antioxidant effect.